High rates of infection associated with the use of maintenance rituximab monotherapy in non-Hodgkin lymphoma.
Azad
A
A
Campbell
P
P
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D001424:Bacterial Infections / Q000139:chemically induced* / Q000209:etiology / Q000382:microbiology; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab